Latest data from the Hong Kong Stock Exchange shows that on December 15, CICC increased its stake in NOVOSENSE (02676) by 144,200 shares at an average price of HK$112.6601 per share, totaling approximately HK$16.2456 million. After the purchase, CICC's total holdings in NOVOSENSE reached about 3.4799 million shares, representing an 18.24% stake.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments